These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 28873971)

  • 1. Clinical practice recommendations for treatment with active vitamin D analogues in children with chronic kidney disease Stages 2-5 and on dialysis.
    Shroff R; Wan M; Nagler EV; Bakkaloglu S; Cozzolino M; Bacchetta J; Edefonti A; Stefanidis CJ; Vande Walle J; Ariceta G; Klaus G; Haffner D; Schmitt CP;
    Nephrol Dial Transplant; 2017 Jul; 32(7):1114-1127. PubMed ID: 28873971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical practice recommendations for native vitamin D therapy in children with chronic kidney disease Stages 2-5 and on dialysis.
    Shroff R; Wan M; Nagler EV; Bakkaloglu S; Fischer DC; Bishop N; Cozzolino M; Bacchetta J; Edefonti A; Stefanidis CJ; Vande Walle J; Haffner D; Klaus G; Schmitt CP;
    Nephrol Dial Transplant; 2017 Jul; 32(7):1098-1113. PubMed ID: 28873969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and management of mineral and bone disorders in infants with CKD: clinical practice points from the ESPN CKD-MBD and Dialysis working groups and the Pediatric Renal Nutrition Taskforce.
    Bacchetta J; Schmitt CP; Bakkaloglu SA; Cleghorn S; Leifheit-Nestler M; Prytula A; Ranchin B; Schön A; Stabouli S; Van de Walle J; Vidal E; Haffner D; Shroff R
    Pediatr Nephrol; 2023 Sep; 38(9):3163-3181. PubMed ID: 36786859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone evaluation in paediatric chronic kidney disease: clinical practice points from the European Society for Paediatric Nephrology CKD-MBD and Dialysis working groups and CKD-MBD working group of the ERA-EDTA.
    Bakkaloglu SA; Bacchetta J; Lalayiannis AD; Leifheit-Nestler M; Stabouli S; Haarhaus M; Reusz G; Groothoff J; Schmitt CP; Evenepoel P; Shroff R; Haffner D;
    Nephrol Dial Transplant; 2021 Feb; 36(3):413-425. PubMed ID: 33245331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survey of attitudes of physicians toward the current evaluation and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD).
    Souqiyyeh MZ; Shaheen FA
    Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):93-101. PubMed ID: 20061700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D, vitamin D receptor and the importance of its activation in patients with chronic kidney disease.
    Bover J; Egido J; Fernández-Giráldez E; Praga M; Solozábal-Campos C; Torregrosa JV; Martínez-Castelao A
    Nefrologia; 2015; 35(1):28-41. PubMed ID: 25611831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D Supplementation for Patients with Chronic Kidney Disease: A Systematic Review and Meta-analyses of Trials Investigating the Response to Supplementation and an Overview of Guidelines.
    Christodoulou M; Aspray TJ; Schoenmakers I
    Calcif Tissue Int; 2021 Aug; 109(2):157-178. PubMed ID: 33895867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recommended calcium intake in adults and children with chronic kidney disease-a European consensus statement.
    Evenepoel P; Jørgensen HS; Bover J; Davenport A; Bacchetta J; Haarhaus M; Hansen D; Gracia-Iguacel C; Ketteler M; McAlister L; White E; Mazzaferro S; Vervloet M; Shroff R
    Nephrol Dial Transplant; 2024 Jan; 39(2):341-366. PubMed ID: 37697718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cinacalcet use in paediatric dialysis: a position statement from the European Society for Paediatric Nephrology and the Chronic Kidney Disease-Mineral and Bone Disorders Working Group of the ERA-EDTA.
    Bacchetta J; Schmitt CP; Ariceta G; Bakkaloglu SA; Groothoff J; Wan M; Vervloet M; Shroff R; Haffner D;
    Nephrol Dial Transplant; 2020 Jan; 35(1):47-64. PubMed ID: 31641778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnosis and treatment of osteoporosis in patients with chronic kidney disease : Joint guidelines of the Austrian Society for Bone and Mineral Research (ÖGKM), the Austrian Society of Physical and Rehabilitation Medicine (ÖGPMR) and the Austrian Society of Nephrology (ÖGN)].
    Cejka D; Wakolbinger-Habel R; Zitt E; Fahrleitner-Pammer A; Amrein K; Dimai HP; Muschitz C
    Wien Med Wochenschr; 2023 Oct; 173(13-14):299-318. PubMed ID: 36542221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. To what extent can we achieve mineral bone metabolism treatment targets suggested by the KDIGO guidelines among chronic kidney disease stage 3 - 5 non-dialysis patients?
    Dincer MT; Ozcan SG; Alagoz S; Karaca C; Gulcicek SH; Trabulus S; Pekpak M; Seyahi N
    Clin Nephrol; 2022 Nov; 98(5):239-246. PubMed ID: 35979902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Utilization of alfacalcidol and active vitamin D analogs in chronic kidney disease].
    Ureña-Torres PA; Cozzolino M; Bover J
    Nephrol Ther; 2018 Jun; 14(4):189-200. PubMed ID: 29545131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Executive summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update: what's changed and why it matters.
    Ketteler M; Block GA; Evenepoel P; Fukagawa M; Herzog CA; McCann L; Moe SM; Shroff R; Tonelli MA; Toussaint ND; Vervloet MG; Leonard MB
    Kidney Int; 2017 Jul; 92(1):26-36. PubMed ID: 28646995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular access in children requiring maintenance haemodialysis: a consensus document by the European Society for Paediatric Nephrology Dialysis Working Group.
    Shroff R; Calder F; Bakkaloğlu S; Nagler EV; Stuart S; Stronach L; Schmitt CP; Heckert KH; Bourquelot P; Wagner AM; Paglialonga F; Mitra S; Stefanidis CJ;
    Nephrol Dial Transplant; 2019 Oct; 34(10):1746-1765. PubMed ID: 30859187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The uses and abuses of Vitamin D compounds in chronic kidney disease-mineral bone disease (CKD-MBD).
    Goldsmith DJ; Massy ZA; Brandenburg V
    Semin Nephrol; 2014 Nov; 34(6):660-8. PubMed ID: 25498384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integral pharmacological management of bone mineral disorders in chronic kidney disease (part II): from treatment of phosphate imbalance to control of PTH and prevention of progression of cardiovascular calcification.
    Bover J; Ureña-Torres P; Lloret MJ; Ruiz C; DaSilva I; Diaz-Encarnacion MM; Mercado C; Mateu S; Fernández E; Ballarin J
    Expert Opin Pharmacother; 2016 Jul; 17(10):1363-73. PubMed ID: 27156578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Native vitamin D in pre-dialysis chronic kidney disease.
    Cardoso MP; Pereira LAL
    Nefrologia (Engl Ed); 2019; 39(1):18-28. PubMed ID: 30274806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D in patients with chronic kidney disease: a position statement of the Working Group "Trace Elements and Mineral Metabolism" of the Italian Society of Nephrology.
    Morrone LF; Bolasco P; Camerini C; Cianciolo G; Cupisti A; Galassi A; Mazzaferro S; Russo D; Russo L; Cozzolino M
    J Nephrol; 2016 Jun; 29(3):305-328. PubMed ID: 27062486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of vitamin D sterols on bone histology in pre-dialysis patients: A prospective controlled study.
    Neto R; Pereira L; Magalhães J; Quelhas-Santos J; Frazão J
    Clin Nephrol; 2022 Jul; 98(1):17-25. PubMed ID: 35200136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin D and Secondary Hyperparathyroidism in Chronic Kidney Disease: A Critical Appraisal of the Past, Present, and the Future.
    Brandenburg V; Ketteler M
    Nutrients; 2022 Jul; 14(15):. PubMed ID: 35893866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.